Wall Street’s major market averages ended lower on Friday as tech stocks fell and U.S. Treasury yields marched higher following the U.S.-China summit ending. Wall Street had a slew of upgrades and ...

The “Buy the Dip” financial news teleprompter readers and the 30-year-old portfolio managers who have never seen a market ...

The intrinsic value estimate for Johnson & Johnson has shifted slightly, with the fair value moving from US$252.42 to ...

Fintel reports that on May 13, 2026, Leerink Partners upgraded their outlook for Johnson & Johnson (NYSE:JNJ) from Market Perform to Outperform. Analyst Price Forecast Suggests 12.12% Upside As of ...

The Dow Jones Industrial Average was lower in afternoon action Wednesday — but well off its worst levels of the session — as ...

Johnson & Johnson (JNJ) stock rises after Leerink Partners upgrades the company to Outperform, citing its growth prospects. Read more here.

Analysts at Leerink Partners upgraded Johnson & Johnson from “Market Perform” to “Outperform,” citing accelerating growth prospects driven by a wave of new drug launches and expanding oncology and ...

Leerink analysts lifted J&J shares to a buy equivalent from hold on Wednesday, citing the company's slate of new drugs.

ONEY selects large cap Russell 1000 stocks with long histories of growth and dividends to add to its portfolio.

The Club's top 10 things to watch Wednesday, May 13 1. Is the reversal out of semiconductor and AI stocks already finished?

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

From Swedish photonics to French satellites and British fuel cells, meet this year's top-performing equities across ...